Sanjay S. Subramanian
Chief Financial OfficerMr. Sanjay S. Subramanian, M.S., M.B.A, is Chief Financial Officer at SCYNEXIS, Inc. since September 9, 2026. He served as Chief Financial Officer of Inozyme Pharma, Inc. since March 21, 2022 until July 01, 2025. and served as its Principal Accounting officer since March 2022 until July 01, 2025 and had been its Senior Vice President since February 2023 until October 2024 and is its Corporate Secretary since September 2022 and serves as its Head of Business Development since October 2024. Mr. Subramanian served as a Chief Accounting Officer and Chief Financial Officer of Ocugen, Inc. since October 01, 2019 until March 18, 2022 and served as its Corporate Secretary since June 2020 until March 18, 2022. He served as a Treasurer at Ocugen, Inc. Mr. Subramanian served as Head of Corporate Development at Ocugen, Inc since January 2021 until March 18, 2022. Mr. Subramanian served as the Chief Financial Officer at Old API Wind-down Ltd. (former name Aralez Pharmaceuticals Inc.) since January 18, 2019 until September 2019. Mr. Subramanian served as Treasurer at Aralez Pharmaceuticals Inc. since October 2015 until January 18, 2019 and served as its Vice President since October 2015. Mr. Subramanian also previously held positions of increasing responsibility at Bausch Health Companies, including playing a key role in the acquisition, financing and post-merger integration of Bausch & Lomb. Prior to joining the company, Mr. Subramanian was the Director of Treasury at Bausch Health Companies from 2013 to October 2015. Mr. Subramanian started his finance career in 2008 at General Motors Co. where he held various positions before leaving as the Treasurer of GM Korea in 2012 and finance leadership rotation program and served as the Managing Director and Treasurer at its Koreadivision as his last role. He obtained his MBA from MIT Sloan School of Management, a Master of Science from both MIT and The Ohio State University and a Bachelor of Technology in mechanical engineering from Indian Institute of Technology, Madras.
Positions
- Company NameSCYNEXIS, Inc.Stock CodeSCYXPositionChief Financial OfficerColleagues
- DGDavid Gonzalez AnguloCEO, President & Director
- GMGuy MacDonaldIndependent Chairman of the Board
- SSScott SukenickChief Legal Officer & Corporate Secretary
- DGDaniella GiganteVice President of Human Resources & Information Technology
- TMTodd MingaSenior Vice President of Research & Development
- AFAnn F. HanhamIndependent Director
- DCDavid C. HastingsIndependent Director
- AAArmando AnidoIndependent Director
